R&D TAX CREDIT OF 25% ON INCREMENTAL BASIS OR A FLAT 5% RATE
Executive Summary
R&D TAX CREDIT OF 25% ON INCREMENTAL BASIS OR A FLAT 5% RATE for qualified research expenses would be established under a bill by Rep. Blute (R-Mass.) and co-sponsored by Rep. Eshoo (D-Calif.). The bill, entitled the "Biotechnology Stimulus Act" (HR 4212), would provide a permanently authorized and higher research and experimentation tax credit directed at fostering biotechnology R&D in place of the current 20% R&D tax credit, which requires annual reauthorization.